Journal of Cancer Therapy

Vol.3 No.2(2012), Paper ID 18656, 5 pages

DOI:10.4236/jct.2012.32017

 

Stress Assessment by Salivary Biomarkers in Patients with Lung Cancer Undergoing Chemotherapy

 

Maiko Kitajima, Yuka Noto, Umi Kudo, Mayumi Urushizaka, Toshiko Tomisawa, Chieko Itaki, Kumiko Kawasaki, Hideaki Yamabe, Akihito Hayashi, Shingo Takanashi

 

Graduate School of Health Sciences, Hirosaki University, Hirosaki, Japan
Graduate School of Health Sciences, Hirosaki University, Hirosaki, Japan
Graduate School of Health Sciences, Hirosaki University, Hirosaki, Japan
Graduate School of Health Sciences, Hirosaki University, Hirosaki, Japan
Graduate School of Health Sciences, Hirosaki University, Hirosaki, Japan
Graduate School of Health Sciences, Hirosaki University, Hirosaki, Japan
Graduate School of Health Sciences, Hirosaki University, Hirosaki, Japan
Graduate School of Health Sciences, Hirosaki University, Hirosaki, Japan
Department of Respiratory Medicine, Hirosaki University Hospital, Hirosaki, Japan.
Department of Respiratory Medicine, Hirosaki University Hospital, Hirosaki, Japan.

 

Copyright © 2012 Maiko Kitajima, Yuka Noto, Umi Kudo, Mayumi Urushizaka, Toshiko Tomisawa, Chieko Itaki, Kumiko Kawasaki, Hideaki Yamabe, Akihito Hayashi, Shingo Takanashi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

 

How to Cite this Article


M. Kitajima, Y. Noto, U. Kudo, M. Urushizaka, T. Tomisawa, C. Itaki, K. Kawasaki, H. Yamabe, A. Hayashi and S. Takanashi, "Stress Assessment by Salivary Biomarkers in Patients with Lung Cancer Undergoing Chemotherapy," Journal of Cancer Therapy, Vol. 3 No. 2, 2012, pp. 127-131. doi: 10.4236/jct.2012.32017.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.